Drugstore Chains · attribution context sourced from stored price moves, stored event labels, and peer-relative residuals inside the XLV constituent company universe.
Review priority 91 · Source rank 0 · Volume 6.2x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.14% · Sector -0.49% · Industry +0.12% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -13.92%Review priority 77 · Source rank 0 · Volume 4.9x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.24% · Sector -0.59% · Industry +0.00% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -7.75%Review priority 77 · Source rank 0 · Volume 3.5x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro -0.03% · Sector +0.04% · Industry +0.00% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -8.62%Review priority 74 · Source rank 60 · Volume 4.3x
Source gap missing_reliable_context_label · Next action research_macro_sector_and_company_news
Decomposition: Macro -3.06% · Sector +1.60% · Industry -2.53% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -6.50%Review priority 68 · Source rank 54 · Volume 1.2x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +5.75% · Sector -3.63% · Industry +0.00% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +8.78%Review priority 68 · Source rank 54 · Volume 1.5x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +5.70% · Sector -5.19% · Industry +0.00% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +8.20%Review priority 65 · Source rank 54 · Volume 1.3x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +8.14% · Sector -6.14% · Industry +0.00% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +7.23%Review priority 65 · Source rank 54 · Volume 1.6x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +3.85% · Sector -2.19% · Industry +0.00% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +6.54%| Date | Label | Move | Residual after context | Scope | Confidence |
|---|---|---|---|---|---|
| Oct 7, 2022 | Closest peers moved -3.98% with this stock | -10.48% | -6.50% | Peer | 58% |
| Mar 17, 2020 | Broad market moved +5.75% with this stock | +10.90% | +8.78% | Macro | 58% |
| Mar 26, 2020 | Broad market moved +5.70% with this stock | +8.71% | +8.20% | Macro | 58% |
| Mar 13, 2020 | Broad market moved +8.14% with this stock | +9.23% | +7.23% | Macro | 58% |
| Mar 2, 2020 | Broad market moved +3.85% with this stock | +8.20% | +6.54% | Macro | 58% |
| Mar 16, 2020 | Broad market moved -12.04% with this stock | -12.31% | -5.66% | Macro | 58% |
| May 1, 2024 | CVS Health Corporation 10-Q: 10-Q | -16.84% | -0.57% | Direct | 70% |
| May 1, 2024 | CVS Health Corporation 8-K: 8-K | -16.84% | -0.57% | Direct | 70% |
| May 1, 2024 | NYSE:CVS 8-K current report items 2.02,9.01 | -16.84% | -0.57% | Direct | 94% |
| Feb 12, 2025 | CVS Health Corporation 10-K: 10-K | +14.95% | +2.96% | Direct | 70% |